Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01952834 · ClinicalTrials.gov registry record · Phase 4
Effect of Probiotic Supplementation on Endothelial Function
A Phase 4 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT01952834 is a Phase 4 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 21 participants.
The verdict
NCT01952834, a Phase 4 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The study is being performed to determine whether probiotics (GoodBelly) improves blood vessel function.Probiotics similar to yogurt are living micro-organisms (beneficial to its host) the lives in the intestine. Patients who have coronary artery disease will be enrolled in this study. The research results will be used to determine if the type of bacteria present in the intestines play a role in the pathogenesis of cardiovascular disease. Patients with coronary artery disease will be enrolled for up to 12 weeks. Patients will take the probiotic for 6 weeks. Following the 6 week period there is a washout period of 4 weeks, and an optional antibiotic study called vancomycin. Patients will take the vancomycin for 10 days. Blood vessel function will be measured by ultrasound before and after the probiotic supplement and vancomycin antibiotic. Blood will also be taken before and after to evaluate for markers of inflammation.
Interventions
- DRUG Vancomycin
- DIETARY_SUPPLEMENT GoodBelly Probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01952834
The ClinicalTrials.gov registry entry for NCT01952834 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin is the first listed.
NCT01952834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01952834 about?
NCT01952834 is a clinical study titled "Effect of Probiotic Supplementation on Endothelial Function". The study is being performed to determine whether probiotics (GoodBelly) improves blood vessel function.Probiotics similar to yogurt are living micro-organisms (beneficial to its host) the lives in the intestine. Patients who have coronary artery disease will be enrolled in this study. The research ...
What is the current status of trial NCT01952834?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2013-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01952834?
The interventions under investigation include: Vancomycin (DRUG), GoodBelly Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01952834?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.